Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001447387-12-000024)

Filing Details

Accession Number:: 0001447387-12-000024
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-10 20:28:17
Reporting Period:: 2012-04-17

Filing Date:: 2012-05-10
Accepted Time:: 2012-05-10 19:28:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088206	Quick-Med Technologies Inc	QMDT	Surgical & Medical Instruments & Apparatus (3841)	650797243

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
937074	P L Partners Phronesis	130 East Chestnut Street Suite 403 Columbus OH 43215		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-04-17	200	$0.10	6,484,112	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-04-17	0	$0.00	6,484,112	No	4	S	Indirect	By Phronesis Partners, L.P.
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-05-08	11,800	$0.10	6,472,312	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-05-08	0	$0.00	6,472,312	No	4	S	Indirect	By Phronesis Partners, L.P.
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-05-08	200	$0.10	6,472,112	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2012-05-08	0	$0.00	6,472,112	No	4	S	Indirect	By Phronesis Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Phronesis Partners, L.P.
No	4	S	Direct
No	4	S	Indirect	By Phronesis Partners, L.P.
No	4	S	Direct
No	4	S	Indirect	By Phronesis Partners, L.P.

Footnotes

(1) These securities are owned by Phronesis Partners, L.P., which is a Reporting Person.
(2) These securities may be deemed to be beneficially owned by James E. Wiggins, the general partner of Phronesis Partners, L.P.